Article on March 25, 2023

Hurting Generic Industry Compelling Pharma To Spend More On R&D

Industry experts contend that largely the research budgets of the top firms have remained flattish in the last two to three years on account of Covid, but the scenario might be changing for some select firms like Sun Pharmaceuticals, Dr Reddy’s Labs, Zydus Lifesciences, Cipla and Biocon Biologics among others due a hurting generic pharma industry

Read More

Zydus Receives Nod From USFDA For Lubiprostone Capsules

Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation). The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad

Read More

Revenue Of Indian Hospitals To Grow By 10-11% In FY23-24: Report

Revenues of private hospitals are set to grow 10-11 per cent in fiscals 2023 and 2024 on the back of healthy bed occupancy and sustenance of high average revenue per occupied bed (ARPOB), supported by increasing domestic demand and pick-up in medical tourism, market intelligence and data analytics firm CRISIL said in a report on Thursday

Read More

WHO Calls For Intensified Action To Eliminate TB From South East Asia

WHO said that, South-East Asia Region bears the world's highest TB burden. In 2021, the Region accounted for more than 45 per cent of global TB incidence and more than half of global TB deaths

Read More